1. Home
  2. BMRN vs CNM Comparison

BMRN vs CNM Comparison

Compare BMRN & CNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • CNM
  • Stock Information
  • Founded
  • BMRN 1996
  • CNM 1996
  • Country
  • BMRN United States
  • CNM United States
  • Employees
  • BMRN N/A
  • CNM N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • CNM Durable Goods
  • Sector
  • BMRN Health Care
  • CNM Consumer Discretionary
  • Exchange
  • BMRN Nasdaq
  • CNM Nasdaq
  • Market Cap
  • BMRN 11.3B
  • CNM 10.8B
  • IPO Year
  • BMRN 1999
  • CNM 2021
  • Fundamental
  • Price
  • BMRN $57.54
  • CNM $64.14
  • Analyst Decision
  • BMRN Buy
  • CNM Buy
  • Analyst Count
  • BMRN 23
  • CNM 11
  • Target Price
  • BMRN $93.14
  • CNM $60.00
  • AVG Volume (30 Days)
  • BMRN 2.5M
  • CNM 1.9M
  • Earning Date
  • BMRN 08-04-2025
  • CNM 09-03-2025
  • Dividend Yield
  • BMRN N/A
  • CNM N/A
  • EPS Growth
  • BMRN 154.69
  • CNM 1.17
  • EPS
  • BMRN 3.40
  • CNM 2.16
  • Revenue
  • BMRN $3,063,608,000.00
  • CNM $7,611,000,000.00
  • Revenue This Year
  • BMRN $12.34
  • CNM $5.90
  • Revenue Next Year
  • BMRN $10.01
  • CNM $5.08
  • P/E Ratio
  • BMRN $16.93
  • CNM $29.69
  • Revenue Growth
  • BMRN 18.36
  • CNM 10.80
  • 52 Week Low
  • BMRN $52.93
  • CNM $37.22
  • 52 Week High
  • BMRN $94.85
  • CNM $65.97
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 47.03
  • CNM 54.59
  • Support Level
  • BMRN $56.45
  • CNM $63.74
  • Resistance Level
  • BMRN $58.62
  • CNM $65.77
  • Average True Range (ATR)
  • BMRN 1.95
  • CNM 1.22
  • MACD
  • BMRN -0.25
  • CNM -0.17
  • Stochastic Oscillator
  • BMRN 15.51
  • CNM 58.63

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About CNM Core & Main Inc.

Core & Main Inc is a specialty distributor focusing on water, wastewater, storm drainage, and fire protection products and services. Catering to municipalities, private water companies, and contractors, it serves municipal, non-residential, and residential markets nationwide. Its diverse product line includes pipes, valves, fittings, storm drainage products, fire protection products, and meter products. Revenue is principally generated from pipes, valves, and fittings. The company operates across three construction sectors: municipal, non-residential, and residential, contributing to reliable infrastructure development nationwide.

Share on Social Networks: